Dr. Martens plc (LON:DOCS) Insider Giles Wilson Buys 194 Shares

Key Points

• Insider Buying: Giles Wilson, an insider at Dr. Martens plc, purchased 194 shares at GBX 77 ($1.03) each, totaling £149.38 ($200.64) on August 11th.
• Stock Performance: As of Tuesday, Dr. Martens' stock traded at GBX 75.60 ($1.02), with a market capitalization of £733.90 million and a P/E ratio of 10.72.
• Analyst Ratings: Royal Bank of Canada lowered its price target for Dr. Martens from GBX 7,000 ($94.02) to GBX 6,000 ($80.59), maintaining a "sector perform" rating.

Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson purchased 194 shares of the firm's stock in a transaction on Monday, August 11th. The shares were acquired at an average cost of GBX 77 ($1.03) per share, with a total value of £149.38 ($200.64).

Giles Wilson also recently made the following trade(s):

• On Friday, July 11th, Giles Wilson purchased 194 shares of Dr. Martens stock. The shares were acquired at an average cost of GBX 77 ($1.03) per share, with a total value of £149.38 ($200.64).
• On Wednesday, June 11th, Giles Wilson purchased 189 shares of Dr. Martens stock. The shares were acquired at an average cost of GBX 79 ($1.06) per share, with a total value of £149.31 ($200.55).

Dr. Martens Stock Performance

DOCS traded up GBX 0.45 ($0.01) during trading on Tuesday, hitting GBX 75.60 ($1.02). 347,907 shares of the stock were exchanged, compared to its average volume of 1,968,943. The firm has a market capitalization of £733.90 million, a P/E ratio of 10.72, a PEG ratio of 6.40 and a beta of 0.11. Dr. Martens plc has a 1-year low of GBX 43.02 ($0.58) and a 1-year high of GBX 85.41 ($1.15). The stock has a fifty day moving average price of GBX 76.91 and a two-hundred day moving average price of GBX 65.13. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.

Dr. Martens (LON:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) EPS for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, sell-side analysts predict that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Royal Bank Of Canada decreased their price target on Dr. Martens from GBX 7,000 ($94.02) to GBX 6,000 ($80.59) and set a "sector perform" rating for the company in a report on Monday, May 19th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Dr. Martens in a research report on Friday, July 11th.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.